DONATE

Why Celiac Disease Belongs in the Women’s Health Conversation

Celiac Canada is bringing community evidence to Parliament to advocate for earlier diagnosis and better care for women.

Written by Melissa Secord, National Executive Director of Celiac Canada,  July 22, 2026

For many women living with celiac disease, receiving a diagnosis takes far too long. The consequences can affect physical and mental health, education, work and family life. 

Celiac Canada is bringing the experiences of these women to Parliament. 

Natalie’s story 

At our recent Parliament Hill event, Natalie Bédard bravely described becoming ill in her early teens with infections, stomach and skin problems, exhaustion and repeated emergency room visits. She became extremely thin and did not reach puberty or have her first period until age 16—an experience that profoundly affected her confidence and self-esteem. 

In her thirties, Natalie was diagnosed with irritable bowel syndrome and told she was a “high-strung, Type-A personality” who needed to slow down. 

“I always knew something was wrong, yet I was repeatedly told nothing was wrong.” 

Five years ago, after her health deteriorated and she was referred among multiple specialists, a rheumatologist finally ordered a celiac blood test. 

“One simple blood test—done decades earlier—could have changed the course of my life.” 

Since her celiac diagnosis, Natalie has also been diagnosed with two additional autoimmune diseases. Today, she speaks out so her three daughters—and other Canadians—can receive an earlier diagnosis. 

What our community told us 

In 2022, approximately 7,500 Canadians participated in Celiac Canada’s State of Celiac Disease in Canada survey. Their responses gave us powerful evidence about the realities of diagnosis and care. 

Compared with men, women were more likely to report: 

  • Longer periods of symptoms before diagnosis 
  • A greater number of celiac-related symptoms 
  • Poorer quality of life before diagnosis 

Nearly 57% of women reported experiencing symptoms for five years or longer before finally receiving a diagnosis. 

Two-thirds of women rated their quality of life before diagnosis as “poor” or “fair.” These are more than statistics. They represent years of missed work, disrupted family life, unanswered questions and preventable health complications. 

A national opportunity to improve women’s health 

Celiac Canada recently made a written submission to the Standing Senate Committee on Social Affairs, Science and Technology in support of Bill S-243, the National Framework for Women’s Health in Canada Act. 

In our submission, we shared findings from our State of Celiac Disease in Canada survey and explained how better healthcare education, earlier recognition of symptoms and improved access to testing could lead to better outcomes for women with celiac disease. 

The proposed legislation calls for the development of a national framework to improve women’s health outcomes and access to care. Among its priorities are: 

  • Better training and education for healthcare professionals 
  • Stronger primary and preventive healthcare for women at every age and life stage 
  • Targeted solutions to improve access to care, including for women in rural and remote communities and those without consistent primary care 
  • Greater investment and coordination in women’s health research and innovation 

These measures could make a meaningful difference for women with celiac disease. 

Bill S-243 completed second reading in the Senate and was referred to committee on March 26, 2026. At the time of writing, it is under consideration by the Senate committee. Follow the bill’s progress through Parliament. 

Why earlier diagnosis matters 

Celiac disease is a serious autoimmune condition affecting approximately one in 100 people. When someone with celiac disease consumes gluten, their immune system damages the small intestine and interferes with the absorption of nutrients such as iron, calcium, folate and vitamin D. 

The broader autoimmune and research gap 

Our State of Celiac Disease in Canada report highlighted inequities within the health system. This aligns with the House of Commons Standing Committee on Health’s 2025 report, Women’s Health in Canada: Closing the Gender Gap, which found that women’s health is less well funded, studied and understood, contributing to underdiagnosis, misdiagnosis and poorly targeted treatments. 

Women also carry a disproportionate burden of autoimmune disease, and autoimmune conditions can co-occur. A woman with celiac disease may also be managing another condition, such as autoimmune thyroid disease, type 1 diabetes or rheumatoid arthritis. Overlapping symptoms can make the path to an accurate diagnosis and coordinated care even more complicated. 

Biological sex can influence immune function, disease risk, symptoms and responses to treatment. Gender-related factors can also shape how symptoms are recognized, how people seek care and how they experience the health system. Research must examine these differences rather than assume that one approach will work equally well for everyone. 

Women must be represented in clinical trials and health studies, with results analyzed by sex and gender where relevant. This can reveal whether diagnostic tools, treatments and follow-up approaches work differently—and help build care that reflects women’s realities. 

The World Health Organization has similarly emphasized that women have distinct and changing health needs and must be at the forefront as leaders and decision-makers in building more equitable health systems. 

For women, undiagnosed or untreated celiac disease can contribute to anemia, osteoporosis and fractures, infertility, adverse pregnancy outcomes, neurological symptoms, anxiety, depression and other health complications. 

The symptoms are not always the ones traditionally associated with celiac disease. A woman may seek care for persistent fatigue, iron deficiency, migraines, joint pain or reproductive health concerns without anyone considering celiac disease as the possible underlying cause. 

That is why healthcare education is so important. When healthcare professionals recognize the many ways celiac disease can present in women, they can recommend appropriate testing sooner. 

Diagnosis can change a life 

Our survey showed that diagnosis and treatment make an enormous difference. Across all respondents, people were more than five times as likely to report a higher quality of life after diagnosis than before it. 

Yet women were less likely to report full recovery from symptoms such as bloating, abdominal pain, weakness, fatigue and iron deficiency. This reinforces the need not only for earlier diagnosis, but also for appropriate follow-up care throughout a woman’s life. 

A strict gluten-free diet remains the only treatment for celiac disease. Identifying the condition and beginning that treatment as early as possible can help prevent complications and give women the opportunity to regain their health. 

Turning community experiences into action 

Celiac Canada’s submission demonstrates how community participation, research and advocacy work together. 

Thousands of people shared their experiences through our national survey. We analyzed that evidence, identified important differences in women’s diagnostic journeys and brought those findings directly to Parliament. 

This is how your support creates change. 

Our donors and community members enable Celiac Canada to collect evidence, educate healthcare professionals and decision-makers, and advocate for health policies that reflect the realities of people living with celiac disease. 

We support Bill S-243 because women deserve to have their symptoms recognized, their concerns taken seriously and their celiac disease diagnosed as early as possible. 

Together, we are helping ensure that celiac disease is part of Canada’s conversation about women’s health—and that fewer women are left waiting years for answers. 

References 

​​1. Penny HA, Shiha MG, Raju SA, et al. The 2026 British Society of Gastroenterology guidelines on the diagnosis and management of adult coeliac disease. Gut. Published online July 12, 2026:gutjnl-2025-337747. doi:10.1136/gutjnl-2025-337747 

​2. Rubio-Tapia A, Hill ID, Semrad C, et al. American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. American Journal of Gastroenterology. 2023;118(1):59-76. doi:10.14309/ajg.0000000000002075 

​3. Blom JJ, Gidrewicz D, Turner J, Duerksen DR, Pinto-Sánchez MI. Diagnosis and management of celiac disease. Can Med Assoc J. 2025;197(38):E1258-E1265. doi:10.1503/cmaj.230091 

​4. Li M, Yu L, Tiberti C, et al. A Report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol. 2009;104(1):154-163. doi:10.1038/ajg.2008.8 

​5. Penny HA, Raju SA, Lau MS, et al. Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult cohorts. Gut. 2021;70(5):876-883. doi:10.1136/gutjnl-2020-320913 

​ ​ 

2025 Platinum Partner 2025 Gold Partner 2025 Silver Sponsor More sponsors

Could It Be Celiac? Take the Symptom Checklist

Help us change
the lives of Gluten-Free Canadians.

thumb Donate thumb Volunteer thumb Partner

Get our monthly newsletter.

News, hot topics, tips, education & more.

Help support the CCA by visiting our shop.

All proceeds will go towards supporting Canadians with Celiac.

Have a question? Ask CCA!

    X
    QUESTIONS?